Skip to content

NAD+evidence-first

The NAD Review
menu

evidence_review

Wonderfeel Youngr NMN Review: Is 900mg Worth It?

Wonderfeel Youngr pairs a high 900mg NMN dose with resveratrol, ergothioneine and hydroxytyrosol. The dose is real — but the blend makes any benefit unprovable.

Wonderfeel Youngr is one of the most visible "premium" NMN products on the market, and it stands out for two reasons: a notably high NMN dose, and a multi-ingredient formula that adds resveratrol, ergothioneine, and hydroxytyrosol on top of the NMN. The brand frames that combination as a more complete longevity formula than plain NMN. This review takes the claims one at a time, honestly: the high dose is genuinely real, but the very thing that makes Youngr distinctive — the blend — is also what makes it impossible to credit any benefit to the NMN specifically. And you pay a premium for the bundle.

What Wonderfeel Youngr is

Youngr is a U.S. direct-to-consumer capsule sold as a daily longevity supplement. Each daily serving delivers, per the label, roughly 900 mg of NMN (nicotinamide mononucleotide, the NAD+ precursor) split across two capsules, plus three supporting ingredients:

  • Resveratrol — a plant polyphenol marketed as a "sirtuin activator" and the classic NMN companion in the so-called "Sinclair stack."
  • Ergothioneine — a diet-derived antioxidant amino acid (concentrated in mushrooms) that the body actively transports and retains.
  • Hydroxytyrosol — an olive-derived polyphenol best known from the Mediterranean-diet literature.

The pitch is that this quartet does more together than NMN alone. To evaluate that fairly, you have to separate two questions the marketing blurs: does the 900 mg NMN dose matter? and does adding the other three ingredients give you anything the trials actually demonstrate?

// What's in the bottle

// IngredientBest human evidenceHonest caveat
NMN (~900 mg)Raises blood NAD+ in RCTs; well toleratedHigh dose not shown to beat a moderate one on benefit
ResveratrolMostly cell/animal sirtuin workVery low human bioavailability
ErgothioneineLinked to lower mortality/CVD riskObservational, not a supplementation trial
HydroxytyrosolLinked to vascular function (CAD)Early; tied to whole olive oil, not capsules
Youngr bundles four ingredients, but the product as sold has never been tested as sold — each claim borrows single-ingredient research.

The 900mg NMN dose: real, but not obviously "more benefit"

Start with what's genuinely true. NMN reliably raises the NAD+ biomarker in human blood and is well tolerated at studied doses — that's the most reproducible thing it does. A single oral dose in healthy men was safely metabolized into NAD precursors 2, and a dose-ranging randomized trial in healthy middle-aged adults found NMN raised blood NAD+ and was well tolerated across the doses tested 1. Youngr's ~900 mg sits at the higher end of what trials have used, and on safety grounds that dose is broadly within the studied range.

But "higher dose" is not the same as "more benefit," and this is the first place the marketing overreaches. The dose-ranging data show the NAD+ biomarker response tends to plateau — pushing the dose up raises the number you'd see on an NAD+ test, but there is no human evidence that a 900 mg dose produces more felt benefit (energy, performance, aging) than a moderate dose. And the felt benefits themselves are the unsettled part of the whole category. NMN's most-cited downstream result — improved muscle insulin sensitivity in prediabetic women 3 — was narrow and contested, and a 2025 systematic review and meta-analysis of NMN and nicotinamide riboside found no reliable improvement in skeletal muscle mass or function when results were pooled 5. Softer signals exist (one trial reported maintained walking speed and better sleep quality in older adults 4), but they're small and subjective. We lay this out in full in does NMN actually work?.

So the honest read on the dose: 900 mg is a real, legitimately high NMN dose that will reliably raise your NAD+ — but the leap from "high dose" to "more anti-aging benefit" is not supported by human trials. You're buying a bigger number, not a proven outcome.

The blend problem: you can't attribute anything to the NMN

Here is the central honesty issue with Youngr, and the reason it can't be reviewed like a clean NMN product. Youngr is a multi-ingredient formula, so even if a user feels better or a biomarker improves, you cannot attribute that result to the NMN — or to any single component. The trials that established NMN raises NAD+ tested NMN alone, not NMN bundled with resveratrol, ergothioneine, and hydroxytyrosol. There is no published human trial of this specific four-ingredient combination showing it does anything that the ingredients don't already do separately. A blend's marketing borrows the credibility of each ingredient's individual research while never testing the actual product — that's the structural problem with proprietary stacks, and it applies squarely here.

Worse, the three add-ons are not equally well-evidenced, and the most heavily marketed one is the weakest.

Resveratrol. The "you need resveratrol with your NMN" story is the shakiest part of the formula. Resveratrol's reputation rests on early-2000s lab and animal work: it was identified as a SIRT1 activator in a test-tube assay that extended yeast lifespan 6, and later reported to improve the health and survival of mice on a high-calorie diet 7. But those are cell and rodent findings, and resveratrol's human track record is undercut by a basic pharmacology problem — it has high absorption but very low bioavailability, because it's metabolized so rapidly that little intact resveratrol reaches the bloodstream 8. So the headline companion ingredient is the one with the poorest human delivery. We dig into why the pairing is more theory than proof in NAD+ and resveratrol: do you need the "Sinclair stack"?.

Ergothioneine. This is arguably the formula's most interesting add-on, and its evidence is genuinely better than resveratrol's — though still observational. Higher blood ergothioneine has been associated with reduced mortality and lower cardiovascular risk in a population study 9, and it's been described as an under-recognized dietary micronutrient that may support healthy ageing 10. That's a real signal — but it's correlational (people with more ergothioneine may simply eat better diets), not proof that supplementing it changes outcomes.

Hydroxytyrosol. The olive polyphenol has plausible vascular and antioxidant data — for example, hydroxytyrosol-enriched olive oil was associated with vascular-function measures in people with chronic coronary disease 11 — but again this is early, mostly tied to whole olive-oil/Mediterranean-diet contexts rather than isolated supplementation at the dose in a capsule blend.

None of these add-ons is junk. The point is narrower and more important: bundling them with NMN means the product as sold has never been tested as sold, and every benefit claim leans on borrowed, single-ingredient (and often observational) research.

// The honest verdict

Is the 900mg + blend worth the premium?

  • The ~900 mg NMN dose is real and reliably raises NAD+ — but a high dose isn't proven to beat a moderate one on actual benefit.
  • It's a 4-ingredient blend, so any effect can't be credited to the NMN — and the combination has never been trial-tested as sold.
  • Resveratrol, the most-hyped companion, has very low human bioavailability; ergothioneine has the best (but only observational) data.
  • You pay a premium for the untested bundle. For most buyers, a cheaper third-party-tested plain NMN gives the same reliable NAD+ rise.

A reality check on the whole category

It's worth anchoring the longevity claims to what the NAD family has actually proven. The single most rigorous hard-endpoint result in this entire space isn't NMN, resveratrol, ergothioneine, or hydroxytyrosol — it's plain nicotinamide, which in a phase 3 randomized trial reduced new non-melanoma skin cancers in high-risk patients 12. That tells you how the evidence really runs: the proven outcomes are narrow and specific, and they are not the broad "feel younger, live longer" promises a premium blend leans on. For the evidence-tiered view of the whole shelf, see the best NAD+ supplements, rated by evidence, and for the underlying science our pillar NAD+ therapy: what the evidence actually shows.

Price: you pay a premium for the bundle

Youngr sits firmly at the premium end of the NMN market (current 2026 pricing), and the premium is explicitly for the multi-ingredient positioning — the 900 mg dose plus the three add-ons — rather than for any demonstrated performance advantage over a well-tested plain NMN. That's the trade to weigh honestly: you're paying more for ingredients whose combined effect has never been tested in a human trial, layered on a precursor whose felt benefits are already unproven. For most buyers, the better-evidenced approach is to choose any well-tested NMN (or NR) on third-party purity and price rather than on a blend story — the buying factor that genuinely varies between products is verification, as we explain in best NMN supplements.

Where Youngr does well — and where it doesn't

To be even-handed:

  • Genuine positives: a real, high (~900 mg) NMN dose; ergothioneine and hydroxytyrosol are legitimate, diet-derived compounds with at least observational human signals; and a brand that publishes a defined formula rather than hiding behind a vague "proprietary blend."
  • The honest limits: the high dose isn't shown to beat a moderate one on benefit; the blend makes any effect unattributable to NMN; resveratrol — the most-marketed companion — has the weakest human bioavailability; and you pay a premium for a combination that's never been trial-tested as sold.

Is Wonderfeel Youngr worth it?

The fair verdict: Youngr is a legitimately formulated, high-dose NMN product with credible (if observational) add-ons — but its distinctive selling points don't hold up as reasons to pay a premium. The 900 mg dose reliably raises NAD+ yet isn't proven to deliver more benefit than a moderate dose; the resveratrol-ergothioneine-hydroxytyrosol blend borrows each ingredient's individual research while the actual product remains untested; and raising NAD+ still isn't the same as feeling or aging better. If you specifically want a multi-ingredient longevity capsule and like the ergothioneine inclusion, Youngr is a defensible (premium) choice. If you mainly want NMN, you'll get the same reliable NAD+ rise — the only well-established effect — from a cheaper, third-party-tested plain NMN.

Bottom line

Wonderfeel Youngr's 900 mg NMN dose is real and its add-ons aren't snake oil — ergothioneine in particular has interesting observational human data. But the formula's headline strengths are also its honesty problems: a high dose isn't shown to outperform a moderate one, the four-ingredient blend means no benefit can be credited to the NMN, and the most-hyped companion (resveratrol) has notoriously poor human bioavailability. You're paying a premium for an untested-as-sold combination on top of a precursor whose felt benefits remain unproven. To compare it on evidence rather than marketing, see best NMN supplements rated by evidence, our best NAD+ supplements ranking, and the NAD+ therapy evidence pillar; for the resveratrol pairing specifically, read NAD+ and resveratrol; and to compare brands and providers on dose, form, and testing, see our NAD+ rankings hub.

This is consumer education, not medical advice — NMN and these polyphenols are supplements, not FDA-approved drugs. If you have a medical condition, are pregnant, or take other medications, talk to a clinician before starting any NMN or NAD+ product.

Frequently asked questions

Is Wonderfeel Youngr's 900mg NMN dose worth it?

The ~900 mg dose is real and high, and it will reliably raise your blood NAD+ — that part is well established. But there is no human evidence that 900 mg produces more felt benefit (energy, performance, anti-aging) than a moderate NMN dose; the NAD+ biomarker response tends to plateau. So you're paying for a bigger number on an NAD+ test, not a proven better outcome.

Can you tell whether the NMN in Youngr is doing anything?

No — and that's the key honesty issue. Youngr is a multi-ingredient blend (NMN plus resveratrol, ergothioneine, and hydroxytyrosol), so even if you feel better, you can't attribute the result to the NMN or to any single ingredient. The NMN trials tested NMN alone; this specific four-ingredient combination has never been tested as sold in a published human trial.

Does the resveratrol in Youngr help?

The resveratrol-with-NMN pairing (the 'Sinclair stack') rests mostly on cell and animal data — resveratrol activating SIRT1 in a test tube and helping mice on a high-calorie diet. In humans its big weakness is pharmacology: resveratrol has high absorption but very low bioavailability, so little intact compound reaches the blood. It's the most-marketed companion ingredient but has the poorest human delivery.

Is Wonderfeel Youngr better than plain NMN?

Not in any way the evidence demonstrates. The only well-established effect of NMN — raising blood NAD+ — you'll also get from a cheaper, third-party-tested plain NMN. Youngr's add-ons (ergothioneine has the best, though observational, data; hydroxytyrosol is early) are legitimate but unproven as a combination, and you pay a premium for a bundle that's never been trial-tested as sold. For most buyers, choosing a well-tested plain NMN on purity and price is the better-evidenced approach.

Is Wonderfeel Youngr safe?

Its NMN dose sits within the range used in human trials, where oral NMN was well tolerated, and ergothioneine and hydroxytyrosol are diet-derived compounds. But these are supplements, not FDA-approved drugs, and the specific four-ingredient blend has not been studied for long-term safety as sold. If you are pregnant, take medications, have a medical condition, or have a cancer history, check with a clinician first.

References

  1. Yi L, Maier AB, Tao R, et al. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.. GeroScience. https://pubmed.ncbi.nlm.nih.gov/36482258/
  2. Irie J, Inagaki E, Fujita M, et al. (2020). Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men.. Endocrine Journal. https://pubmed.ncbi.nlm.nih.gov/31685720/
  3. Yoshino M, Yoshino J, Kayser BD, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.. Science. https://pubmed.ncbi.nlm.nih.gov/33888596/
  4. Morifuji M, Nagata M (2024). Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study.. GeroScience. https://pubmed.ncbi.nlm.nih.gov/38789831/
  5. Prokopidis K, Moriarty F, Bahat G, et al. (2025). The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis.. Journal of Cachexia, Sarcopenia and Muscle. https://pubmed.ncbi.nlm.nih.gov/40275690/
  6. Howitz KT, Bitterman KJ, Cohen HY, et al. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.. Nature. https://pubmed.ncbi.nlm.nih.gov/12939617/
  7. Baur JA, Pearson KJ, Price NL, et al. (2006). Resveratrol improves health and survival of mice on a high-calorie diet.. Nature. https://pubmed.ncbi.nlm.nih.gov/17086191/
  8. Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK (2004). High absorption but very low bioavailability of oral resveratrol in humans.. Drug Metabolism and Disposition. https://pubmed.ncbi.nlm.nih.gov/15333514/
  9. Smith E, Ottosson F, Hellstrand S, et al. (2020). Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease.. Heart. https://pubmed.ncbi.nlm.nih.gov/31672783/
  10. Tian X, Cioccoloni G, Sims JN, et al. (2023). Ergothioneine: an underrecognised dietary micronutrient required for healthy ageing?. British Journal of Nutrition. https://pubmed.ncbi.nlm.nih.gov/38018890/
  11. Ikonomidis I, Katsanos S, Triantafyllidi H, et al. (2023). Association of hydroxytyrosol enriched olive oil with vascular function in chronic coronary disease.. European Journal of Clinical Investigation. https://pubmed.ncbi.nlm.nih.gov/36912212/
  12. Chen AC, Martin AJ, Choy B, et al. (2015). A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention (ONTRAC).. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/26488693/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

continue_reading